Old Web
English
Sign In
Acemap
>
Paper
>
Designing a therapeutic SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups
Designing a therapeutic SARS-CoV-2 T-cell-inducing vaccine for high-risk patient groups
2020
Hans-Georg Rammensee
Stefan Stevanovic
Cécile Gouttefangeas
Sonja Heidu
Reinhild Klein
Beate Preuß
Juliane S. Walz
Annika Nelde
Sebastian P. Haen
Michael Reth
Jianying Yang
Ghazaleh Tabatabai
Hans Bösmüller
Helen Hoffmann
Michael Schindler
Oliver Planz
Karl-Heinz Wiesmüller
Markus W. Löffler
Keywords:
Immunology
high risk patients
T cell
severe acute respiratory syndrome coronavirus 2
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]